Balance Sheet Formycon AG

Equities

FYB

DE000A1EWVY8

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 16:35:18 16/01/2026 GMT			After hours 19:41:14
24.05 ^EUR	-0.62%		23.82	-0.94%

12-23	Formycon Obtains US FDA Approval for Interchangeable Lucentis Biosimilar	MT
12-23	Formycon AG - FDA approves biologics license application (BLA) for additional ranibizumab biosimilar under trade name Nufymco	RE

e3e6d739b52db8d0aaf8a09.Vjgb_OpJzBN-FwhoW7t_79pVbhKmAgdmGVo3pWpCVUk.ZHB8s60BoiorQnkSb4k-27dsG0LzMFU0RjBgwiw0YQh7C1SGrQC9UCpBUQ

Published financial data: FORMYCON AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	34.23M	36.96M	42.5M	77.7M	69.67M
Total Revenues	34.23M	36.96M	42.5M	77.7M	69.67M
Cost of Goods Sold, Total	25.47M	35.96M	30.42M	54.39M	54.84M
Gross Profit	8.76M	1.01M	12.07M	23.3M	14.83M
Selling General & Admin Expenses, Total	10.03M	13M	12.89M	14.12M	21.39M
Provision for Bad Debts	-	-	-	447K	-78K
R&D Expenses	-	-	16.91M	9.16M	16.5M
Depreciation & Amortization - (IS)	915K	943K	-	-	-
Other Operating Expenses	3.56M	372K	0	388K	489K
Other Operating Expenses, Total	14.5M	14.31M	29.8M	24.12M	38.3M
Operating Income	-5.74M	-13.31M	-17.73M	-816K	-23.47M
Interest Expense, Total	-106K	-166K	-125K	-80K	-1.09M
Interest And Investment Income	1.93K	2K	302K	2.82M	3.6M
Net Interest Expenses	-104K	-164K	177K	2.74M	2.51M
Income (Loss) On Equity Invest.	-	-	76.84M	-19.36M	-15.17M
Currency Exchange Gains (Loss)	11.8K	-34K	93K	-92K	63K
Other Non Operating Income (Expenses)	-	1K	-22.79M	-14K	-17K
EBT, Excl. Unusual Items	-5.83M	-13.5M	36.6M	-17.55M	-36.09M
Impairment of Goodwill	-	-	-	-	-44.53M
Gain (Loss) On Sale Of Investments	-2.78K	-3K	-	96.62M	21.09M
Asset Writedown	-	-	-	-	-84.72M
EBT, Incl. Unusual Items	-5.84M	-13.51M	36.6M	79.07M	-144M
Income Tax Expense	89.6K	-30K	604K	3.28M	-18.58M
Earnings From Continuing Operations	-5.93M	-13.48M	35.99M	75.8M	-126M
Net Income to Company	-5.93M	-13.48M	35.99M	75.8M	-126M
Net Income - (IS)	-5.93M	-13.48M	35.99M	75.8M	-126M
Net Income to Common Incl Extra Items	-5.93M	-13.48M	35.99M	75.8M	-126M
Net Income to Common Excl. Extra Items	-5.93M	-13.48M	35.99M	75.8M	-126M
Per Share Items
Net EPS - Basic	-0.54	-1.22	2.62	4.76	-7.18
Basic EPS - Continuing Operations	-0.54	-1.22	2.62	4.76	-7.18
Basic Weighted Average Shares Outstanding	11M	11.06M	13.72M	15.92M	17.49M
Net EPS - Diluted	-0.54	-1.22	2.59	4.72	-7.18
Diluted EPS - Continuing Operations	-0.54	-1.22	2.59	4.72	-7.18
Diluted Weighted Average Shares Outstanding	11M	11.06M	13.88M	16.05M	17.49M
Normalized Basic EPS	-0.33	-0.76	1.67	-0.69	-1.29
Normalized Diluted EPS	-0.33	-0.76	1.65	-0.68	-1.29
Supplemental Items
EBITDA	-4.83M	-12.36M	-17.02M	-214K	114M
EBITA	-5.52M	-13.05M	-17.69M	-778K	-15.85M
EBIT	-5.74M	-13.31M	-17.73M	-816K	-23.47M
EBITDAR	-	-	-	-195K	114M
Effective Tax Rate - (Ratio)	-1.54	0.22	1.65	4.14	12.88
Total Current Taxes	-	-	202K	-8K	2.06M
Total Deferred Taxes	-	-	401K	3.28M	-20.64M
Normalized Net Income	-3.65M	-8.44M	22.87M	-10.97M	-22.56M
Interest on Long-Term Debt	-	-	68K	80K	269K
Supplemental Operating Expense Items
Marketing Expenses	-	-	329K	608K	959K
Selling and Marketing Expenses	-	-	1.44M	841K	1.3M
General and Administrative Expenses	-	-	11.45M	13.26M	20.07M
Research And Development Expense From Footnotes	40.95M	55.38M	57.69M	44.84M	46.24M
Net Rental Expense, Total	-	-	-	19K	18K
Imputed Operating Lease Interest Expense	-	-	-	308	7.82K
Imputed Operating Lease Depreciation	-	-	-	18.69K	10.18K
Stock-Based Comp., G&A Exp. (Total)	-	-	-	998K	1.33M
Stock-Based Comp., Other (Total)	-	-	535K	626K	344K
Total Stock-Based Compensation	-	-	535K	1.62M	1.68M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	42.01M	25.03M	9.82M	27.04M	41.83M
Short Term Investments	238K	150K	-	-	-
Total Cash And Short Term Investments	42.25M	25.18M	9.82M	27.04M	41.83M
Accounts Receivable, Total	6.89M	7.75M	15.48M	28.17M	30.71M
Other Receivables	-	-	-	131K	91K
Total Receivables	6.89M	7.75M	15.48M	28.3M	30.8M
Inventory	1.24M	1.86M	571K	467K	262K
Other Current Assets, Total	130K	3.21M	4.64M	11.34M	22.13M
Total Current Assets	50.51M	37.99M	30.5M	67.15M	95.02M
Gross Property Plant And Equipment	7.94M	8.13M	18.34M	20.57M	24.7M
Accumulated Depreciation	-4.44M	-4.84M	-6.83M	-8.24M	-10.13M
Net Property Plant And Equipment	3.5M	3.28M	11.52M	12.33M	14.57M
Long-term Investments	20.67M	23.66M	186M	167M	152M
Goodwill	276K	118K	44.53M	44.53M	-
Other Intangibles, Total	223K	590K	488M	508M	444M
Loans Receivable Long-Term	-	-	92.3M	90.91M	66.13M
Deferred Tax Assets Long-Term	280K	310K	-	-	-
Other Long-Term Assets, Total	138K	379K	-	-	1K
Total Assets	75.6M	66.33M	854M	890M	772M
Liabilities
Accounts Payable, Total	4.48M	4.73M	11.32M	16.32M	17.44M
Accrued Expenses, Total	1.54M	1.88M	1.76M	2.88M	3.07M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	20.79M	20.48M	-
Current Portion of Leases	-	-	925K	1.19M	1.5M
Current Income Taxes Payable	-	-	108K	65K	2.03M
Other Current Liabilities	1.15M	3.28M	15.77M	28.37M	9.86M
Total Current Liabilities	7.17M	9.89M	50.67M	69.31M	33.89M
Long-Term Debt	-	-	20M	50K	-
Long-Term Leases	-	-	7.59M	7.82M	9.1M
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	-	-	120M	123M	102M
Other Non Current Liabilities	398K	372K	299M	188M	165M
Total Liabilities	7.56M	10.26M	497M	388M	310M
Common Stock, Total	11M	11.06M	15.13M	16.05M	17.66M
Retained Earnings	-19.95M	-33.43M	-1.97M	73.83M	-51.84M
Comprehensive Income and Other	76.99M	78.44M	343M	413M	496M
Total Common Equity	68.04M	56.07M	357M	503M	462M
Total Equity	68.04M	56.07M	357M	503M	462M
Total Liabilities And Equity	75.6M	66.33M	854M	890M	772M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	11M	11.06M	15.13M	16.05M	17.66M
ECS Total Common Shares Outstanding	11M	11.06M	15.13M	16.05M	17.66M
Book Value / Share	6.19	5.07	23.57	31.32	26.16
Tangible Book Value	67.54M	55.36M	-176M	-50.19M	17.73M
Tangible Book Value Per Share	6.14	5	-11.66	-3.13	1
Total Debt	0	0	49.31M	29.54M	10.59M
Net Debt	-42.25M	-25.18M	39.49M	2.5M	-31.24M
Debt Equivalent Oper. Leases	-	-	-	152K	144K
Equity Method Investments, Total	-	-	-	167M	152M
Account Code - Inventory Valuation	6	6	5	5	5
Inventories - Raw Materials, Total	240K	359K	-	-	-
Inventories - Work In Process, Total	755K	1.12M	-	-	-
Inventories - Others	241K	378K	-	-	-
Land - (BS)	613K	613K	-	-	-
Machinery, Total	7.33M	7.51M	5.88M	6.71M	7.77M
Full Time Employees	103	125	205	238	250
Part Time Employees	28	46	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-5.93M	-13.48M	35.99M	75.8M	-126M
Depreciation & Amortization - CF	691K	685K	1.7M	1.69M	131M
Amortization of Goodwill and Intangible Assets - (CF)	224K	258K	42K	38K	7.62M
Depreciation & Amortization, Total	915K	943K	1.74M	1.72M	139M
Amortization of Deferred Charges, Total - (CF)	-	-	123K	163K	197K
(Gain) Loss From Sale Of Asset	37K	175K	36K	41K	163K
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	-	-	535K	1.62M	1.68M
Other Operating Activities, Total	134K	164K	-54.05M	-76.38M	-26.63M
Change In Accounts Receivable	-	-	3.08M	-12.7M	-2.73M
Change In Inventories	-2.48M	-4.68M	-363K	104K	206K
Change In Accounts Payable	1.95M	550K	-2.77M	5M	1.12M
Change in Other Net Operating Assets	269K	2.15M	-3.2M	-5.22M	-10.41M
Cash from Operations	-5.1M	-14.18M	-18.88M	-9.85M	-23.22M
Capital Expenditure	-558K	-704K	-551K	-1.03M	-1.54M
Sale of Property, Plant, and Equipment	-	-	-	-	5K
Cash Acquisitions	-	-	1.11M	-	-
Sale (Purchase) of Intangible assets	-92K	-547K	-26.21M	-20.17M	-28.4M
Investment in Marketable and Equity Securities, Total	-	-2.99M	-11.42M	-	-
Other Investing Activities, Total	2K	2K	2K	3.82M	28.48M
Cash from Investing	-648K	-4.24M	-37.07M	-17.38M	-1.46M
Long-Term Debt Issued, Total	-	-	40M	-	-
Total Debt Issued	-	-	40M	-	-
Long-Term Debt Repaid, Total	-	-	-908K	-24.24M	-42.7M
Total Debt Repaid	-	-	-908K	-24.24M	-42.7M
Issuance of Common Stock	25.75M	1.51M	1.76M	70.49M	83.09M
Other Financing Activities, Total	-106K	-166K	-118K	-1.8M	-912K
Cash from Financing	25.64M	1.35M	40.74M	44.44M	39.48M
Miscellaneous Cash Flow Adjustments	1K	-	-	-	-
Net Change in Cash	19.89M	-17.07M	-15.21M	17.22M	14.8M
Supplemental Items
Cash Interest Paid	106K	166K	118K	69K	913K
Cash Income Tax Paid (Refund)	-	-	331K	166K	4K
Levered Free Cash Flow	-3.4M	-10.42M	-23.88M	-18.99M	67.14M
Unlevered Free Cash Flow	-3.33M	-10.32M	-23.8M	-18.94M	67.82M
Change In Net Working Capital	6.28K	1.69M	-11.64M	746K	28.32M
Net Debt Issued / Repaid	-	-	39.09M	-24.24M	-42.7M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-5.56	-11.72	-2.4	-0.06	-1.76
Return on Total Capital	-6.17	-13.4	-4.74	-0.11	-2.92
Return On Equity %	-10.2	-21.72	17.45	17.64	-26.06
Return on Common Equity	-10.2	-21.72	17.45	17.64	-26.06
Margin Analysis
Gross Profit Margin %	25.6	2.72	28.41	30	21.29
SG&A Margin	29.31	35.16	30.33	18.18	30.7
EBITDA Margin %	-14.1	-33.45	-40.05	-0.28	163.82
EBITA Margin %	-16.12	-35.3	-41.62	-1	-22.75
EBIT Margin %	-16.77	-36	-41.72	-1.05	-33.68
Income From Continuing Operations Margin %	-17.31	-36.46	84.69	97.55	-180.37
Net Income Margin %	-17.31	-36.46	84.69	97.55	-180.37
Net Avail. For Common Margin %	-17.31	-36.46	84.69	97.55	-180.37
Normalized Net Income Margin	-10.65	-22.83	53.82	-14.12	-32.37
Levered Free Cash Flow Margin	-9.92	-28.19	-56.19	-24.44	96.36
Unlevered Free Cash Flow Margin	-9.73	-27.91	-56	-24.38	97.33
Asset Turnover
Asset Turnover	0.53	0.52	0.09	0.09	0.08
Fixed Assets Turnover	9.51	10.9	4.26	6.52	5.18
Receivables Turnover (Average Receivables)	5.79	5.05	3.1	3.56	2.37
Inventory Turnover (Average Inventory)	31.02	23.27	78.01	104.8	150.45
Short Term Liquidity
Current Ratio	7.05	3.84	0.6	0.97	2.8
Quick Ratio	6.86	3.33	0.5	0.8	2.14
Operating Cash Flow to Current Liabilities	-0.71	-1.43	-0.37	-0.14	-0.69
Days Sales Outstanding (Average Receivables)	63.17	72.28	117.72	102.52	154.65
Days Outstanding Inventory (Average Inventory)	11.8	15.69	4.68	3.48	2.43
Average Days Payable Outstanding	46.6	45.99	112.18	92.91	113.07
Cash Conversion Cycle (Average Days)	28.37	41.98	10.22	13.1	44.02
Long Term Solvency
Total Debt/Equity	-	-	13.83	5.87	2.29
Total Debt / Total Capital	-	-	12.15	5.55	2.24
LT Debt/Equity	-	-	7.74	1.56	1.97
Long-Term Debt / Total Capital	-	-	6.8	1.48	1.93
Total Liabilities / Total Assets	10	15.47	58.23	43.53	40.15
EBIT / Interest Expense	-54.38	-80.16	-141.82	-10.2	-21.55
EBITDA / Interest Expense	-45.71	-74.48	-127.91	11.35	105.97
(EBITDA - Capex) / Interest Expense	-50.99	-78.72	-132.32	-1.51	104.55
Total Debt / EBITDA	-	-	-3.08	32.53	0.09
Net Debt / EBITDA	8.75	2.04	-2.47	2.75	-0.27
Total Debt / (EBITDA - Capex)	-	-	-2.98	-244.1	0.09
Net Debt / (EBITDA - Capex)	7.85	1.93	-2.39	-20.67	-0.27
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.23	8	16.07	82.83	-10.32
Gross Profit, 1 Yr. Growth %	-20.13	-88.52	19.41	93.05	-36.35
EBITDA, 1 Yr. Growth %	254.46	156.12	27.67	-98.69	-53.44K
EBITA, 1 Yr. Growth %	142.67	127.24	26.52	-95.42	1.94K
EBIT, 1 Yr. Growth %	152.52	131.73	26.63	-95.2	2.78K
Earnings From Cont. Operations, 1 Yr. Growth %	158.39	127.4	-370.82	110.59	-265.81
Net Income, 1 Yr. Growth %	158.39	127.4	-370.82	110.59	-265.81
Normalized Net Income, 1 Yr. Growth %	153.51	131.49	-357.59	-129.21	105.66
Diluted EPS Before Extra, 1 Yr. Growth %	134.9	126.07	-315.2	82.24	-252.22
Accounts Receivable, 1 Yr. Growth %	40.13	12.37	29.63	82.05	9
Inventory, 1 Yr. Growth %	203.77	50.08	173.21	-18.21	-43.9
Net Property, Plant and Equip., 1 Yr. Growth %	-5.41	-6.23	36.59	7.04	18.2
Total Assets, 1 Yr. Growth %	41.16	-12.26	1.11K	4.29	-13.33
Tangible Book Value, 1 Yr. Growth %	41.94	-18.02	-419.76	-71.55	-135.32
Common Equity, 1 Yr. Growth %	41.12	-17.59	537.99	40.99	-8.14
Cash From Operations, 1 Yr. Growth %	244.63	177.78	41.37	-47.83	135.79
Capital Expenditures, 1 Yr. Growth %	-39.54	26.16	39.85	86.75	50.15
Levered Free Cash Flow, 1 Yr. Growth %	9.34K	194.94	163.05	-18.95	-453.52
Unlevered Free Cash Flow, 1 Yr. Growth %	18.07K	197.58	162.9	-18.89	-458.04
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-10.78	5.59	11.32	45.67	28.04
Gross Profit, 2 Yr. CAGR %	-31.6	-69.72	23.37	51.83	10.85
EBITDA, 2 Yr. CAGR %	-22.44	201.32	69.84	-87.33	164.58
EBITA, 2 Yr. CAGR %	-11.97	139.56	64.55	-76.41	-3.35
EBIT, 2 Yr. CAGR %	-10.2	141.92	64.63	-75.86	17.45
Earnings From Cont. Operations, 2 Yr. CAGR %	-8.63	142.41	131.27	138.81	86.86
Net Income, 2 Yr. CAGR %	-8.63	142.41	131.27	138.81	86.86
Normalized Net Income, 2 Yr. CAGR %	-9.35	142.25	134.69	11.14	-22.5
Diluted EPS Before Extra, 2 Yr. CAGR %	-15.44	130.45	98.06	98.04	66.55
Accounts Receivable, 2 Yr. CAGR %	15.5	25.48	41.64	53.62	40.87
Inventory, 2 Yr. CAGR %	0.81	113.57	151.88	49.48	-32.26
Net Property, Plant and Equip., 2 Yr. CAGR %	0.4	-5.81	11.58	20.92	12.48
Total Assets, 2 Yr. CAGR %	38.13	11.29	225.5	254.84	-4.92
Tangible Book Value, 2 Yr. CAGR %	44.21	7.87	62.71	-4.62	-68.3
Common Equity, 2 Yr. CAGR %	43.07	7.84	130.88	199.92	13.81
Cash From Operations, 2 Yr. CAGR %	-38.05	209.41	112.11	-14.12	10.91
Capital Expenditures, 2 Yr. CAGR %	-23.4	-12.67	3.84	61.61	67.45
Levered Free Cash Flow, 2 Yr. CAGR %	-39.87	1.6K	184.27	44.64	69.28
Unlevered Free Cash Flow, 2 Yr. CAGR %	-40.52	2.27K	184.71	44.65	70.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.68	-4.91	8.62	31.34	23.92
Gross Profit, 3 Yr. CAGR %	2.01	-62.27	3.25	43.23	13.63
EBITDA, 3 Yr. CAGR %	83.33	15.5	132.09	-66.9	104.57
EBITA, 3 Yr. CAGR %	52.1	22.38	98.14	-50.8	4.28
EBIT, 3 Yr. CAGR %	54.13	23.18	98.3	-50.03	18.79
Earnings From Cont. Operations, 3 Yr. CAGR %	55.32	23.82	150.37	124.16	111.46
Net Income, 3 Yr. CAGR %	55.32	23.82	150.37	124.16	111.46
Normalized Net Income, 3 Yr. CAGR %	54.51	23.9	151.48	38.23	36.44
Diluted EPS Before Extra, 3 Yr. CAGR %	47.1	17.37	124.36	92.64	81.41
Accounts Receivable, 3 Yr. CAGR %	-13.14	14.45	46.52	54	37.02
Inventory, 3 Yr. CAGR %	28.82	15.13	11.98	73.12	7.82
Net Property, Plant and Equip., 3 Yr. CAGR %	2.45	-1.86	45.99	10.05	20
Total Assets, 3 Yr. CAGR %	34.85	18.74	151.67	122.73	121.81
Tangible Book Value, 3 Yr. CAGR %	39.86	19.46	54.77	-9.01	-31.5
Common Equity, 3 Yr. CAGR %	38.62	19.04	94.84	95.88	102.17
Cash From Operations, 3 Yr. CAGR %	6.96	2.16	133.6	32.89	20.25
Capital Expenditures, 3 Yr. CAGR %	8.88	-9.54	-15.8	26.28	57.69
Levered Free Cash Flow, 3 Yr. CAGR %	-7.96	3.52	772.27	85.93	94.83
Unlevered Free Cash Flow, 3 Yr. CAGR %	-8.37	3.1	991.09	86.16	95.67
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.12	13.61	7.94	12.56	16.01
Gross Profit, 5 Yr. CAGR %	1.72	-24.66	7.9	4.47	6.22
EBITDA, 5 Yr. CAGR %	24.71	29.88	85.11	-51.56	142.48
EBITA, 5 Yr. CAGR %	52.68	26.4	62.35	-35.77	47.46
EBIT, 5 Yr. CAGR %	53.9	26.9	62.43	-35.16	59.5
Earnings From Cont. Operations, 5 Yr. CAGR %	59.31	27.08	86.82	60.58	122.72
Net Income, 5 Yr. CAGR %	59.31	27.08	86.82	60.58	122.72
Normalized Net Income, 5 Yr. CAGR %	58.53	27.13	87.45	19.84	73.42
Diluted EPS Before Extra, 5 Yr. CAGR %	53.31	22.21	72.57	44.34	99.15
Accounts Receivable, 5 Yr. CAGR %	20.12	8.26	8.03	40.38	44.23
Inventory, 5 Yr. CAGR %	39.7	24.03	-0.24	-17.41	-8.42
Net Property, Plant and Equip., 5 Yr. CAGR %	6.52	1.49	28.75	28.83	31.53
Total Assets, 5 Yr. CAGR %	22.73	21.37	94.3	86.35	70.5
Tangible Book Value, 5 Yr. CAGR %	23.26	22.71	48.19	9.1	-17.92
Common Equity, 5 Yr. CAGR %	22.29	21.83	69.42	72.16	57.13
Cash From Operations, 5 Yr. CAGR %	58.08	22.99	35.25	-5.83	73.41
Capital Expenditures, 5 Yr. CAGR %	-3.59	-11.88	4.97	1.59	10.85
Levered Free Cash Flow, 5 Yr. CAGR %	39.52	13	40.54	15.12	351.01
Unlevered Free Cash Flow, 5 Yr. CAGR %	39.66	12.83	40.62	15.01	417.21